Expression of ICAM-1 and VCAM-1 in human malignant mesothelioma

Journal of Pathology

Volumn 179, Issue 3, 1996, Pages 266-271

  Ruco, Luigi P ^a   De Laat, Petronella A J M ^b   Matteucci, Cristian ^c   Bernasconi, Sergio ^c   Sciacca, Francesca Maria ^c   Van Der Kwast, Theo H ^b   Hoogsteden, Henk C ^b   Uccini, Stefania ^a   Mantovani, Alberto ^d   Versnel, Marjan A ^b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^d UNIVERSITY OF BRESCIA   (Italy)

Author keywords

intercellular adhesion molecule 1 (ICAM 1); malignant mesothelioma; regulation of expression; vascular cell adhesion molecule 1 (VCAM 1)

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 13; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ARTICLE; CELL ADHESION; CELL CULTURE; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIGAND BINDING; MALIGNANT MESOTHELIOMA; PRIORITY JOURNAL;

BLOTTING, NORTHERN; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOENZYME TECHNIQUES; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-13; MESOTHELIOMA; NEOPLASM PROTEINS; RNA, MESSENGER; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR CELL ADHESION MOLECULE-1;

EID: 9444232240     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(199607)179:3<266::AID-PATH592>3.0.CO;2-Y     Document Type: Article

References (26)

1. Dustin ML, Rothlein R, Bhan AK, Dinarello CA, Springer TA. Induction by IL-1 and interferon gamma: tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1). J Immunol 1986; 137: 245-254.
2. Wawryk SO, Novotny JR, Wicks IP, et al. The role of the LFA-1/ICAM-1 interaction in human leukocyte homing and adhesion. Immunol Rev 1989; 108: 135-161.
3. Osborn L, Hession C, Tizard R, et al. Direct expression cloning of vascular cell adhesion molecule 1, a cytokine induced endothelial protein that binds to lymphocytes. Cell 1989; 59: 1203-1211.
4. Rice GE, Munro JM, Bevilacqua MP. Inducible adhesion molecule 110 (INCAM-110) is an endothelial receptor for lymphocytes. A CD11/CD18-independent adhesion mechanism. J Exp Med 1990; 171: 1369-1374.
5. Rice GE, Munro JM, Corless T, Bevilacqua MP. Vascular and non-vascular expression of INCAM-110. A target for mononuclear leukocyte adhesion in normal and inflamed human tissues. Am J Pathol 1991; 138: 385-393.
6. Uccini S, Ruco LP, Monardo F, Lesnoni La Parola I, Cerimele D, Baroni CD. Molecular mechanisms involved in intraepithelial lymphocyte migration: a comparative study in skin and tonsil. J Pathol 1993; 169: 413-419.
7. Elices MJ, Osborn L, Takada Y, et al. VCAM-1 on activated endothelium intracts with the leukocyte integrin VLA-4/fibronectin binding site. Cell 1990; 60: 577-584.
8. Hynes RO. Integrins: versatility, modulation, and signalling in cell adhesion. Cell 1992; 69: 11-25.
9. Oppenheimer-Marks N, Davis LS, Bogue DT, Ramberg J, Lipsky PE. Differential utilization of ICAM-1 and VCAM-1 during the adhesion and transendothelial migration of human T lymphocytes. J Immunol 1991; 147: 2913-2921.
10. Koopman J, Parmentier HK, Schuurman H-J, Newman W, Meijer CJLM, Pals ST. Adhesion of human B cells to follicular dendritic cells involves both the lymphocyte function associated antigen 1/intercellular adhesion molecule 1 and very late antigen 4/vascular cell adhesion molecule 1 pathways. J Exp Med 1991; 173: 1297-1304.
11. Van Seventer GA, Newman W, Shimizu Y, et al. Analysis of T cell stimulation by superantigen plus major histocompatibility complex class II molecules and by CD3 monoclonal antibody: costimulation by purified adhesion ligands VCAM-1, ICAM-1, but not ELAM-1. J Exp Med 1991; 174: 901-913.
12. Shiohara T, Moriya N, Saizawa K, Gotoh C, Yagita H, Nagashima M. Evidence for involvement of lymphocyte function-associated antigen 1 in T cell migration to epidermis. J Immunol 1991; 146: 840-845.
13. Ruco LP, Stoppacciaro A, Uccini S. Expression of ICAM-1 and VCAM-1 in undifferentiated nasopharyngeal carcinoma (lymphoepithelioma) and in malignant epithelial tumors. Hum Pathol 1994; 25: 924-928.
14. Jonjić N, Peri G, Bernasconi S. Expression of adhesion molecules and chemotactic cytokines in cultured human mesothelial cells. J Exp Med 1992; 176: 1165-1174.
15. Versnel MA, Bouts MJ, Hoogsteden HC, Van Der Kwast TH, Delahaye M, Hagemeijer A. Establishment of human malignant mesothelioma cell lines. Int J Cancer 1989; 44: 256-260.
16. Chirgwin JM, Przybya AE, Macdonald RJ, Rutter WJ. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 1979; 18: 5294-5298.
17. Muller WA, Ratti CM, Macdonnel SL, Cohn ZA. A human endothelial cell-restricted, externally disposed plasmalemmal protein enriched in intercellular junctions. J Exp Med 1989; 170: 399-414.
18. Bevilacqua MP, Pober JS, Mendrick DL, Cotran RS, Gimbrone MA Jr. Identification of an inducible endothelial-leukocyte adhesion molecule. Proc Natl Acad Sci USA 1987; 84: 9238-9242.
19. Mantovani A, Bottazzi B, Colotta F, Sozzani S, Ruco L. The origin and function of tumor associated macrophages. Immunol Today 1992; 13: 265-270.
20. Johnson JP, Stade BG, Holzmann B, Schwable W, Riethmuller G. De nova expression of intercellular adhesion molecule 1 in melanoma correlates with increased risk of metastasis. Proc Natl Acad Sci USA 1989; 86: 641-644.
21. Tsujisaki M, Imai K, Hirata H. Detection of circulating intercellular adehsion molecule-1 antigen in malignant diseases. Clin Exp Immunol 1991; 85: 3-8.
22. Vanky F, Wang P, Patarroyo M, Klein E. Expression of adhesion molecule ICAM-1 and major histocompatibility complex class I antigens on human cells is required for their interaction with autologous lymphocytes in vitro. Cancer Immunol Immunother 1990; 31: 19-27.
23. Gearing AJH, Newman W. Circulating adhesion molecules in disease. Immunol Today 1993; 14: 506-512.
24. Sheibani K, Esteban JM, Bailey A, Battifora H, Weiss LM. Immunopathologic and molecular studies as an aid in the diagnosis of malignant mesothelioma. Hum Pathol 1992; 23: 107-116.
25. Brown RW, Clark GM, Tandon AK, Allred DC. Multiple-marker immunohistochemical phenotypes distinguishing malignant pleural mesothelioma from pulmonary adenocarcinoma. Hum Pathol 1993; 24: 347-354.
26. O'Hara CJ, Corson JM, Pinkus GS, Stahel RA. ME1. A monoclonal antibody that distringuishes epithelial type malignant mesothelioma from pulmonary adenocarcinoma and extrapulmonary malignancies Am J Pathol 1990; 136: 421-428.